Sex and gender perspectives in colorectal cancer
2023 · ESMO Open · 94 citations
https://doi.org/10.1016/j.esmoop.2023.101204
J
Javier Ros
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
200
Papers
1.7K
Citations
24
h-index
44
i10-index
Javier Ros is an academic researcher from Hebron University. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Intraperitoneal and Appendiceal Malignancies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 24, co-authored 170 publications.
ORCID: 0000-0002-8137-5415Papers by this author
worksImmunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers
2023 · Cancers · 41 citations
https://doi.org/10.3390/cancers15174245
The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer
2021 · Current Treatment Options in Oncology · 21 citations
https://doi.org/10.1007/s11864-021-00913-5
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
2024 · ESMO Open · 15 citations
https://doi.org/10.1016/j.esmoop.2024.103696
Targeting HER2 in Metastatic Colorectal Cancer: Current Therapies, Biomarker Refinement, and Emerging Strategies
2025 · Drugs · 4 citations
https://doi.org/10.1007/s40265-025-02253-2
Supplementary Table S2 from Negative Hyperselection of Patients with HER2<sup>+</sup> and <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 Study
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25011240.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat